Journal: bioRxiv
Article Title: A PKM2-YAP reciprocal repartitioning modulates invasion of breast cancer cells
doi: 10.1101/2025.07.10.664113
Figure Lengend Snippet: (A) Representative confocal photomicrographs of breast cancer MDA-MB-231 cells untreated (top row of micrographs) or treated with 5□μM Verteporfin, YAP signalling inhibitor (second row from top) grown on 20 kPa (stiff) hydrogels coated with Collagen I and observed after 24□h of culture with staining by□DNA (white using DAPI, left panel) and F-actin (green using phalloidin, right panel (n□= 3). Scale bar: 20□μm. Graphs showing total cell area (top) and aspect ratio (second from top) of individual MDA-MB-231 cells untreated and treated with 5□μM Verteporfin on 20 kPa hydrogels (n□= 3, N□= 30 single cells). (B) Representative confocal photomicrographs of MDA-MB-231 cells untreated (top row of micrographs) or treated with 5□μM Verteporfin (second row from top) grown on 20 kPa (stiff) hydrogels coated with Collagen I and observed after 24□h of culture with staining by□DNA (white using DAPI, left panel) and PKM2 (Red, right panel) and adjacent scatter plot graph (right) depicting nucleus/cytoplasm ratio of PKM2 between untreated and 5□μM Verteporfin treated MDA-MB-231 cells on 20 kPa hydrogels (n=3, N=50). (n□= 3). Scale bar: 20□μm. (C) Epifluorescence photomicrographs of MDA-MB-231 cells with their migration tracks for 3 hours, control (left) and treated with 5□μM Verteporfin (right) on 20 kPa hydrogels and scatter plot graph (right) depicting migration speed (n=3, N > 20). See also Video S7, S8. (D) Graph measuring fold change of intracellular pyruvate (first from left), intracellular lactate (second from left), extracellular pyruvate (third from left), extracellular lactate (last from left) between untreated and 5□μM Verteporfin treated MDA-MB-231 cells on 20 kPa hydrogels (n=3). (E) Schematic depiction of PKM2-YAP reciprocal repartitioning. Error bars denote mean□±□SEM. Unpaired Student’s□ t □test was performed for statistical significance (* P □≤ 0.05, ** P □≤ 0.01, *** P □< 0.001, **** P □< 0.0001).
Article Snippet: The primary antibodies used in our studies are against PKM2 (4053S, CST), YAP (14074S, CST).
Techniques: Staining, Migration, Control